close
close
This business is engaged in the manufacture and sale of products for household use such as roux curry, roux stew, retort curry, spice products, and starch noodles, as well as products for commercial use in Japan.
Net Sales for FY2023
¥126.3
billion
Operating Profit
¥10.8
billion
This business is engaged in the manufacture, sale, and mail-order sales of health foods and functional beverages such as Ukon No Chikara, C1000, and Ichinichibun No Vitamin in Japan.
Net Sales for FY2023
¥16.9
billion
Operating Profit
¥2.5
billion
This business is engaged in the manufacture and sale of soybean-related products such as tofu, curry products, and functional foods, mainly in the United States, China, and Southeast Asia. It is characterized by the development of multiple different businesses to solve problems and capture business opportunities in the countries where it operates.
Net Sales for FY2023
¥56.4
billion
Operating Profit
¥3.1
billion
This business involves the planning and operation of restaurants around the world, including “Curry House CoCo Ichibanya”, which offers Japanese-style curry.
Net Sales for FY2023
¥55.1
billion
Operating Profit
¥3.4
billion
This business contributes to the strengthening of synergy among the group companies through the manufacture and sale of prepared dishes, etc., the import and sale of food ingredients, and the analysis of food products.
Net Sales for FY2023
¥55.0
billion
Operating Profit
¥1.9
billion
Proportion of net sales represents a proportion before the elimination of inter-segment transactions.